CSP-2503

Source: Wikipedia, the free encyclopedia.
CSP-2503
Clinical data
ATC code
  • none
Identifiers
  • 2-[(4-naphthalen-1-ylpiperazin-1-yl)methyl]hexahydropyrrolo[1,2-a]pyrazine-1,4-dione
JSmol)
  • O=C4N5CCCC5C(=O)N(CN3CCN(c2c1ccccc1ccc2)CC3)C4
  • InChI=1S/C22H26N4O2/c27-21-15-25(22(28)20-9-4-10-26(20)21)16-23-11-13-24(14-12-23)19-8-3-6-17-5-1-2-7-18(17)19/h1-3,5-8,20H,4,9-16H2 checkY
  • Key:CTZWGZSINBFHFD-UHFFFAOYSA-N checkY
  (verify)

CSP-2503 is a

QSAR studies.[2][3] In rat studies, CSP-2503 has demonstrated anxiolytic effects, and thus has been suggested as a treatment for anxiety in humans with a multimodal mechanism of action.[1]

See also

References

  1. ^
    PMID 15777774
    .
  2. PMID 12668005
    .
  3. PMID 15801844
    .
Retrieved from "https://en.wikipedia.org/w/index.php?title=CSP-2503&oldid=1167058529"